Concepedia
Statistics
Publications
4
Citations
233
H-Index
Active since
2004
Affiliations
Institut Gustave Roussy(Current)
The Barbara Ann Karmanos Cancer Institute
S. Gadgeel is an author at Institut Gustave Roussy specializing in radiation oncology, pharmacotherapy, and drug discovery.
Top concepts
MedicineOncologyPharmacologyCancer TherapyDrug DiscoveryCancer ResearchPharmacotherapyMolecular OncologyRadiation OncologyPre-clinical Pharmacology
Publications per year
2004–2017
Assessment of <i>EGFR</i> Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
Chris Karlovich, Jonathan W. Goldman, Jong‐Mu Sun et al. · Clinical Cancer Research · 2016 · 178 citations · Full text
Evaluation of the VeriStrat ® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
S. Gadgeel, Glenwood Goss, Jean‐Charles Soria et al. · Lung Cancer · 2017 · 28 citations · Full text
Phase I and Pharmacokinetics (PK) of DJ-927, an oral taxane, in patients (Pts) with advanced cancers
Serajuddaula Syed, M. Beeram, Chris H. Takimoto et al. · Journal of Clinical Oncology · 2004 · 16 citations
Oncology, Advanced Cancers, Medicine +15
3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement
Andréa Varga, D. Ross Camidge, Lecia V. Sequist et al. · European Journal of Cancer · 2015 · 11 citations
1–4 of 4